Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Roper Technologies Inc V.ROP.P


Primary Symbol: ROP

Roper Technologies, Inc. is a diversified technology company. The Company operates businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. It operates through three segments: Application Software, Network Software and Technology Enabled Products. The Application Software segment includes Aderant, CBORD, Clinisys, Data Innovations, Deltek, Frontline, IntelliTrans, PowerPlan, Strata and Vertafore. The Network Software segment includes ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP and SoftWriters. The Technology Enabled Products segment includes CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS and Verathon. Aderant is a comprehensive management software solution for law and other professional services firms. ConstructConnect is a cloud-based data, collaboration, and estimating automation software solutions to a network of pre-construction contractors.


NDAQ:ROP - Post by User

Comment by diamondhandson Oct 29, 2021 4:29pm
162 Views
Post# 34066039

RE:RE:RE:unreal

RE:RE:RE:unreal

Tim I think the demand side of the business is very clear, just look at revenue growth during the most difficult economic time in the last decade (FY20 / covid). They did very well considering those challenges and adapted very quickly. Aside that there is fundamentally a lot of demand for these sustainable and competitive products, they are also successful because their operating business model is extremely well thought-out: there is diversity of sector and products (medical, other), they have many sales channels (ecommerce, direct to consumer, b2b, etc.), and they are smart in terms of product innovation and gaining market power in their supply chain.

This is absolutely not the time to prioritize profits. It is the time to build the brand, scale, and strategic positioning to capitlize on the enormous opportunity provided by the simple fact that this market just started transitioning to sustainable products. (this is a very strong and undeniable macro theme across many many sectors) 

Of course profits are nice, but I'd rather make a percentage profit on $1bn in sales in 3-5 years (or whatever larger amounts sooner), than trying to squeeze profits out of 50-60-80 million in sales at the expense of strategic positioning.

Just think, 10% of 80 million is only 8 million. 10% of 1 billion is 100 million.  Think bigger, think longer term, otherwise you are not a transformational growth compay, you are just a small business. 

Big difference
 

<< Previous
Bullboard Posts
Next >>